These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Carrier cell-mediated cell lysis of squamous cell carcinoma cells by squamous cell carcinoma antigen 1 promoter-driven oncolytic adenovirus. Hamada K, Zhang T, Desaki J, Nakashiro K, Itoh H, Tani K, Koyama Y, Hamakawa H. J Gene Med; 2010 Jun; 12(6):545-54. PubMed ID: 20527047 [Abstract] [Full Text] [Related]
5. E1A, E1B double-restricted replicative adenovirus at low dose greatly augments tumor-specific suicide gene therapy for gallbladder cancer. Fukuda K, Abei M, Ugai H, Kawashima R, Seo E, Wakayama M, Murata T, Endo S, Hamada H, Hyodo I, Yokoyama KK. Cancer Gene Ther; 2009 Feb; 16(2):126-36. PubMed ID: 18818710 [Abstract] [Full Text] [Related]
6. Double E1B 19 kDa- and E1B 55 kDa-deleted oncolytic adenovirus in combination with radiotherapy elicits an enhanced anti-tumor effect. Kim J, Kim PH, Yoo JY, Yoon AR, Choi HJ, Seong J, Kim IW, Kim JH, Yun CO. Gene Ther; 2009 Sep; 16(9):1111-21. PubMed ID: 19494843 [Abstract] [Full Text] [Related]
7. ADP-overexpressing adenovirus elicits enhanced cytopathic effect by induction of apoptosis. Yun CO, Kim E, Koo T, Kim H, Lee YS, Kim JH. Cancer Gene Ther; 2005 Jan; 12(1):61-71. PubMed ID: 15375379 [Abstract] [Full Text] [Related]
8. Prolonged survival of mice with multiple liver metastases of human colon cancer by intravenous administration of replicable E1B-55K-deleted adenovirus with E1A expressed by CEA promoter. Sagawa T, Takahashi M, Sato T, Sato Y, Lu Y, Sumiyoshi T, Yamada Y, Iyama S, Fukaura J, Sasaki K, Hamada H, Miyanishi K, Takayama T, Kato J, Niitsu Y. Mol Ther; 2004 Dec; 10(6):1043-50. PubMed ID: 15564136 [Abstract] [Full Text] [Related]
9. E1A, E1B double-restricted adenovirus for oncolytic gene therapy of gallbladder cancer. Fukuda K, Abei M, Ugai H, Seo E, Wakayama M, Murata T, Todoroki T, Tanaka N, Hamada H, Yokoyama KK. Cancer Res; 2003 Aug 01; 63(15):4434-40. PubMed ID: 12907616 [Abstract] [Full Text] [Related]
10. Oncolytic effects of adenovirus mutant capable of replicating in hypoxic and normoxic regions of solid tumor. Cho WK, Seong YR, Lee YH, Kim MJ, Hwang KS, Yoo J, Choi S, Jung CR, Im DS. Mol Ther; 2004 Nov 01; 10(5):938-49. PubMed ID: 15509511 [Abstract] [Full Text] [Related]
11. Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model. Melquist JJ, Kacka M, Li Y, Malaeb BS, Elmore J, Baseman AG, Hsieh JT, Koeneman KS. Urol Oncol; 2006 Nov 01; 24(4):362-71. PubMed ID: 16818192 [Abstract] [Full Text] [Related]
12. E1AF/PEA3 reduces the invasiveness of SiHa cervical cancer cells by activating serine proteinase inhibitor squamous cell carcinoma antigen. Iwasaki M, Nishikawa A, Akutagawa N, Fujimoto T, Teramoto M, Sakaguchi Y, Kato H, Ito M, Yoshida K, Kudo R. Exp Cell Res; 2004 Oct 01; 299(2):525-32. PubMed ID: 15350549 [Abstract] [Full Text] [Related]
13. Selective targeting of HPV-16 E6/E7 in cervical cancer cells with a potent oncolytic adenovirus and its enhanced effect with radiotherapy in vitro and vivo. Wang W, Sima N, Kong D, Luo A, Gao Q, Liao S, Li W, Han L, Wang J, Wang S, Lu Y, Wang D, Xu G, Zhou J, Meng L, Ma D. Cancer Lett; 2010 May 01; 291(1):67-75. PubMed ID: 19903581 [Abstract] [Full Text] [Related]
14. [Adenovirus-delivered tissue inhibitor of metalloproteinases-3 transfection increases the sensitivity of cervical cancer cells to cisplatin]. Zhang Y, Lin C, Qian HL, Lang JH, Fu M, Zhang XY, Liang X, Duan H, Xiang Y. Zhonghua Zhong Liu Za Zhi; 2007 Jan 01; 29(1):25-9. PubMed ID: 17575689 [Abstract] [Full Text] [Related]
15. E1B 55-kDa deleted, Ad5/F35 fiber chimeric adenovirus, a potential oncolytic agent for B-lymphocytic malignancies. Wang G, Li G, Liu H, Yang C, Yang X, Jin J, Liu X, Qian Q, Qian W. J Gene Med; 2009 Jun 01; 11(6):477-85. PubMed ID: 19340843 [Abstract] [Full Text] [Related]
16. A novel A33 promoter-based conditionally replicative adenovirus suppresses tumor growth and eradicates hepatic metastases in human colon cancer models. Cafferata EG, Macció DR, Lopez MV, Viale DL, Carbone C, Mazzolini G, Podhajcer OL. Clin Cancer Res; 2009 May 01; 15(9):3037-49. PubMed ID: 19336523 [Abstract] [Full Text] [Related]
17. Aberrant expression of serpin squamous cell carcinoma antigen 2 in human tumor tissues and cell lines: evidence of protection from tumor necrosis factor-mediated apoptosis. Takeda A, Kajiya A, Iwasawa A, Nakamura Y, Hibino T. Biol Chem; 2002 May 01; 383(7-8):1231-6. PubMed ID: 12437110 [Abstract] [Full Text] [Related]
18. Anti-tumor efficacy of a transcriptional replication-competent adenovirus, Ad-OC-E1a, for osteosarcoma pulmonary metastasis. Li X, Jung C, Liu YH, Bae KH, Zhang YP, Zhang HJ, Vanderputten D, Jeng MH, Gardner TA, Kao C. J Gene Med; 2006 Jun 01; 8(6):679-89. PubMed ID: 16570242 [Abstract] [Full Text] [Related]
20. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo. Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ. Breast Cancer Res Treat; 2009 Sep 01; 117(1):45-54. PubMed ID: 18791823 [Abstract] [Full Text] [Related] Page: [Next] [New Search]